|
시장보고서
상품코드
2078900
가상 종양학 시장 : 구성요소별, 암 유형별, 용도별, 최종사용자별, 지역별Virtual Oncology Market, By Component, By Cancer Type, By Application, By End User, By Geography |
||||||
가상 종양학 시장 규모는 2026년 55억 9,000만 달러로 추정되며, 2033년까지 179억 달러에 이를 전망입니다. 또한, 2026-2033년 CAGR 18.1%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 55억 9,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 18.10% | 2033년 시장 규모 예측 : | 179억 달러 |
가상 종양학은 기술을 활용하여 원격으로 암 치료 및 지원 서비스를 제공하는 헬스케어 분야의 신흥 분야입니다. 여기에는 원격의료, 가상 진료, 원격 모니터링, 맞춤형 치료 계획 등 다양한 디지털 솔루션이 포함됩니다. 가상 종양학의 목적은 환자의 치료 성과를 높이고, 의료 서비스에 대한 접근성을 확대하며, 전반적인 환자 경험을 개선하는 데 있습니다.
기술의 발전과 전 세계 암 유병률 증가에 따라, 가상 종양학은 최근 큰 주목을 받고 있습니다. 이러한 접근 방식에는 환자의 이동 시간과 비용을 절감할 수 있고, 전문가의 의견을 더 쉽게 접할 수 있으며, 환자의 건강 상태를 원격으로 모니터링할 수 있다는 점 등 몇 가지 장점이 있습니다. 또한, 개별 환자의 필요와 희망에 기반한, 보다 맞춤형 치료 옵션도 가능하게 합니다.
시장 역학:
가상 종양학 시장은 향후 몇 년 동안 상당한 성장이 예상됩니다. 그 주요 요인으로는 암 발병률 증가, 원격 의료 서비스에 대한 수요 증가, 그리고 기술의 발전 등을 들 수 있습니다. 또한, 코로나19 팬데믹으로 인해 병원 및 진료소가 대면 진료 축소 및 감염 위험 최소화에 주력하는 가운데, 가상 종양학 솔루션의 도입이 더욱 가속화되고 있습니다.
그러나 시장의 성장을 저해할 수 있는 몇 가지 과제도 존재합니다. 데이터 보안 및 환자 개인정보 보호에 대한 우려와 규제상의 장벽은 시장 참여자들에게 큰 걸림돌이 되고 있습니다. 또한, 가상 기술에 정통한 숙련된 의료 인력의 부족과 이러한 시스템 도입에 따른 높은 비용 역시 시장 확대를 제한할 가능성이 있습니다.
그렇긴 하지만, 가상 종양학 시장은 기존 시장 참여자와 신규 시장 진출기업 모두에게 몇 가지 기회를 제공합니다. 가상 종양학 분야에서 인공지능(AI) 및 머신러닝 알고리즘의 도입 확대는 진단, 치료 계획 수립, 환자 모니터링의 개선에 기여할 가능성이 있습니다. 또한, 혁신적인 솔루션 개발과 환자 참여도 향상을 목표로 하는 기술 기업과 의료 서비스 제공업체 간의 협력이 시장 성장을 주도할 것으로 예측됩니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 업체들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 또한, 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 가상 종양학 시장의 주요 기업 프로파일을 소개했습니다.
- 본 조사에서 다룬 주요 기업으로는 Flatiron Health, McKesson Corporation, Cerner Corporation, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Crisp, Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, C-TAC Health, Oscar Health, NXGN Management, LLC, Epic Systems Corporation, Optum, Inc., Orchestrate.AI, CureMatch, Inc., Oncora Medical 등이 포함됩니다.
- 본 보고서에서 도출된 인사이트은 마케팅 담당자와 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있도록 해줍니다.
- 세계 가상 종양학 시장에 관한 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 가상 종양학 시장 분석에 사용된 다양한 전략 매트릭스를 활용함으로써 의사결정 과정을 지원하는 이점을 얻을 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 가상 종양학 시장 : 컴포넌트별, 2021년-2033년
제5장 가상 종양학 시장 : 암 유형별, 2021년-2033년
제6장 가상 종양학 시장 : 용도별, 2021년-2033년
제7장 가상 종양학 시장 : 최종사용자별, 2021년-2033년
제8장 가상 종양학 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 섹션
LSH 26.07.10Virtual Oncology Market is estimated to be valued at USD 5.59 Bn in 2026 and is expected to reach USD 17.90 Bn by 2033, growing at a compound annual growth rate (CAGR) of 18.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.59 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 18.10% | 2033 Value Projection: | USD 17.90 Bn |
Virtual oncology is an emerging field in healthcare that utilizes technology to provide remote cancer care and support services. It encompasses various digital solutions such as telemedicine, virtual consultations, remote monitoring, and personalized treatment plans. The aim of virtual oncology is to improve patient outcomes, increase access to care, and enhance the overall patient experience.
With advancements in technology and the increasing prevalence of cancer worldwide, virtual oncology has gained significant traction in recent years. This approach offers several benefits, including reduced travel time and costs for patients, improved access to expert opinions, and the ability to monitor patients' health remotely. It also allows for more personalized treatment options based on individual patient needs and preferences.
Market Dynamics:
The virtual oncology market is expected to witness substantial growth in the coming years, primarily driven by factors such as the increasing prevalence of cancer, the growing need for remote healthcare services, and advancements in technology. Additionally, the COVID-19 pandemic has further accelerated the adoption of virtual oncology solutions as hospitals and clinics focus on reducing in-person visits and minimizing the risk of infections.
However, there are certain challenges that may restrain market growth. Concerns regarding data security and patient privacy, along with regulatory barriers, pose significant hurdles for market players. Moreover, the lack of skilled healthcare professionals proficient in virtual technologies and the high costs associated with implementing such systems may limit the market's expansion.
Nevertheless, the virtual oncology market presents several opportunities for both existing and new market players. The increasing adoption of artificial intelligence (AI) and machine learning algorithms in virtual oncology can help improve diagnosis, treatment planning, and patient monitoring. Additionally, collaborations between technology companies and healthcare providers to develop innovative solutions and enhance patient engagement are expected to drive market growth.
Key Features of the Study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global virtual oncology market based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies.
- Key companies covered in this study include Flatiron Health, McKesson Corporation, Cerner Corporation, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Crisp, Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, C-TAC Health, Oscar Health, NXGN Management, LLC, Epic Systems Corporation, Optum, Inc, Orchestrate.AI, CureMatch, Inc., Oncora Medical
- Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics.
- The global virtual oncology market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders will benefit from the various strategy matrices used in analyzing the global virtual oncology market, which will aid in decision-making processes.
Virtual Oncology Market Segmentation:
- Virtual Oncology Market, By Component (Revenue, USD Bn, 2021 - 2033)
- Software
- Service
- Hardware
- Virtual Oncology Market, By Cancer Type (Revenue, USD Bn, 2021 - 2033)
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Liver Cancer
- Bladder Cancer
- Others (Pancreatic, Ovarian etc.)
- Virtual Oncology Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Precision Medicine
- Patient Care Management
- Research & Development
- Clinical Trials
- Diagnosis & Treatment Decision Making
- Data Management
- Others (Billing Management, Regulatory Compliance etc.)
- Virtual Oncology Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals & Diagnostic Imaging Centers
- Academic Institutions & Research Centers
- Pharma & Biotech Companies
- Contract Research Organizations (CROs)
- Others (Reference Laboratories, Pharmacies etc.)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top companies in Virtual Oncology Market:
- Flatiron Health
- McKesson Corporation
- Cerner Corporation
- Koninklijke Philips N.V.
- Siemens Healthcare Private Limited
- Crisp
- Varian Medical Systems, Inc.
- Elekta AB
- Accuray Incorporated
- C-TAC Health
- Oscar Health
- NXGN Management, LLC
- Epic Systems Corporation
- Optum, Inc
- CureMatch, Inc.
- Oncora Medical
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Virtual Oncology, By Component
- Market Virtual Oncology, By Cancer Type
- Market Virtual Oncology, By Application
- Market Virtual Oncology, By End User
- Market Virtual Oncology, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising prevalence of cancer globally
- Restraints
- Data privacy and security concerns
- Opportunities
- Emerging markets exhibit significant growth potential
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Virtual Oncology Market , By Component, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Service
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Virtual Oncology Market , By Cancer Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others (Pancreatic, Ovarian etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Virtual Oncology Market , By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Patient Care Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Research & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Clinical Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Diagnosis & Treatment Decision Making
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Data Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others (Billing Management, Regulatory Compliance etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Virtual Oncology Market , By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals & Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Academic Institutions & Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Pharma & Biotech Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others (Reference Laboratories, Pharmacies etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Virtual Oncology Market , By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022-2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- North Africa
- South Africa
- Central Africa
9. Competitive Landscape
- Flatiron Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- McKesson Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cerner Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Siemens Healthcare Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Crisp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Varian Medical Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elekta AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Accuray Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- C-TAC Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oscar Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NXGN Management, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Epic Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Optum, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AI
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CureMatch, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Oncora Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
